- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2051-5960
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Fusions involving BCOR and CREBBP are rare events in infiltrating glioma ; volume:8 ; number:1 ; day:3 ; month:6 ; year:2020 ; pages:1-11 ; date:12.2020
Acta Neuropathologica Communications ; 8, Heft 1 (3.6.2020), 1-11, 12.2020
- Urheber
-
Pisapia, David J.
Ohara, Kentaro
Bareja, Rohan
Wilkes, David C.
Hissong, Erika
Croyle, Jaclyn A.
Kim, Joon-Hyung
Saab, Jad
MacDonald, Theresa Y.
Beg, Shaham
O’Reilly, Catherine
Kudman, Sarah
Rubin, Mark A.
Elemento, Olivier
Sboner, Andrea
Greenfield, Jeffrey
Mosquera, Juan Miguel
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s40478-020-00951-4
- URN
-
urn:nbn:de:101:1-2020080503050319476001
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:59 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Pisapia, David J.
- Ohara, Kentaro
- Bareja, Rohan
- Wilkes, David C.
- Hissong, Erika
- Croyle, Jaclyn A.
- Kim, Joon-Hyung
- Saab, Jad
- MacDonald, Theresa Y.
- Beg, Shaham
- O’Reilly, Catherine
- Kudman, Sarah
- Rubin, Mark A.
- Elemento, Olivier
- Sboner, Andrea
- Greenfield, Jeffrey
- Mosquera, Juan Miguel
- SpringerLink (Online service)
Ähnliche Objekte (12)
GOPC:ROS1 and other ROS1 fusions represent a rare but recurrent drug target in a variety of glioma types
Clinical characteristics and detection of MYB-QKI fusions in patients with angiocentric glioma
Fusions-Fieber
Interpolative Fusions
Gene therapy of malignant glioma with retroviral vectors and tumor-infiltrating progenitor cells
Identification of neoepitopes recognized by tumor-infiltrating lymphocytes (TILs) from patients with glioma
MET fusions and splicing variants convergently define a subgroup of glioma sensitive to MET inhibitors
Gemeindereform "Fusions Prämien"
Fusions- und Transformationsmanagement
Interkingdom gene fusions
Correction : identification of neoepitopes recognized by tumor-infiltrating lymphocytes (TILs) from patients with glioma
Novel gene fusions identified as new drug targets in paediatric glioma and their pre-clinical characterisation
GOPC:ROS1 and other ROS1 fusions represent a rare but recurrent drug target in a variety of glioma types
Clinical characteristics and detection of MYB-QKI fusions in patients with angiocentric glioma
Fusions-Fieber
Interpolative Fusions
Gene therapy of malignant glioma with retroviral vectors and tumor-infiltrating progenitor cells
Identification of neoepitopes recognized by tumor-infiltrating lymphocytes (TILs) from patients with glioma
MET fusions and splicing variants convergently define a subgroup of glioma sensitive to MET inhibitors
Gemeindereform "Fusions Prämien"
Fusions- und Transformationsmanagement
Interkingdom gene fusions
Correction : identification of neoepitopes recognized by tumor-infiltrating lymphocytes (TILs) from patients with glioma
Novel gene fusions identified as new drug targets in paediatric glioma and their pre-clinical characterisation
GOPC:ROS1 and other ROS1 fusions represent a rare but recurrent drug target in a variety of glioma types
Clinical characteristics and detection of MYB-QKI fusions in patients with angiocentric glioma
Fusions-Fieber
Interpolative Fusions
Gene therapy of malignant glioma with retroviral vectors and tumor-infiltrating progenitor cells
Identification of neoepitopes recognized by tumor-infiltrating lymphocytes (TILs) from patients with glioma
MET fusions and splicing variants convergently define a subgroup of glioma sensitive to MET inhibitors
Gemeindereform "Fusions Prämien"
Fusions- und Transformationsmanagement
Interkingdom gene fusions
Correction : identification of neoepitopes recognized by tumor-infiltrating lymphocytes (TILs) from patients with glioma